We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Greiner Bio-One

Download Mobile App





Cellink Relaunches Real-Time qPCR Instrument for COVID-19

By HospiMedica International staff writers
Posted on 04 Apr 2020
Print article
Illustration
Illustration
CELLINK (Boston, MA, USA) has begun reselling its qPCR instrument which can be used for the quantification and genotyping of human viral pathogens, such as SARS-CoV-2. CELLINK is offering the instrument at a low-cost point to help advance research related to the COVID-19 pandemic and provide scientists with the tools they need to make a difference.

CELLINK is a niche life-science company that develops and delivers life-science solutions for cell culturing. It focuses on three application areas, including bioprinting, analysis and liquid handling & bioprocessing to deliver a complete solution in its life science niche. The company targets to develop and commercialize cell culture technologies, enabling researchers to print human organs and tissues for pharmaceutical and cosmetic applications.

CELLINK’s qPCR instrument for the quantification and genotyping of human viral pathogens, such as SARS-CoV-2, uses a laboratory technique of molecular biology based on the polymerase chain reaction. It monitors the amplification of a targeted DNA molecule during the PCR (i.e., in real time). The instrument includes dual channels and is open source, allowing users to use any kit to run their samples. It is designed as a high-quality, low-throughput qPCR cycler. The instrument is easy to use and runs a sample in 20-40 minutes.

Related Links:
CELLINK


Print article
Radcal

Channels

Copyright © 2000-2020 Globetech Media. All rights reserved.